Michael Geffner Immunovant, Inc. (IMVT) insider trading activity

IMVT Quotes by TradingView

Michael Geffner is Chief Medical Officer of Immunovant, Inc.. Currently has a direct ownership of 233,888 shares of IMVT, which is worth approximately $6.43 Million. The most recent transaction as insider was on Apr 01, 2025, when has been sold 101,574 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 234K
73.29% 3M change
61.44% 12M change
Total Value Held $6.43 Million

Michael Geffner Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 01 2025
BUY
Grant, award, or other acquisition
-
101,574 Added 30.28%
233,888 Common Stock
Jan 22 2025
SELL
Open market or private sale
$62,678 $23.59 p/Share
2,657 Reduced 1.97%
132,314 Common Stock
Oct 23 2024
SELL
Open market or private sale
$94,171 $29.53 p/Share
3,189 Reduced 2.31%
134,971 Common Stock
Jul 24 2024
SELL
Open market or private sale
$95,938 $27.76 p/Share
3,456 Reduced 2.44%
138,160 Common Stock
Apr 24 2024
SELL
Open market or private sale
$94,242 $28.9 p/Share
3,261 Reduced 2.25%
141,616 Common Stock
Apr 02 2024
BUY
Grant, award, or other acquisition
-
54,978 Added 27.51%
144,877 Common Stock
Jan 26 2024
SELL
Open market or private sale
$385,656 $38.18 p/Share
10,101 Reduced 10.1%
89,899 Common Stock
MG

Michael Geffner

Chief Medical Officer
New York, NY

Track Institutional and Insider Activities on IMVT

Follow Immunovant, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMVT shares.

Notify only if

Insider Trading

Get notified when an Immunovant, Inc. insider buys or sells IMVT shares.

Notify only if

News

Receive news related to Immunovant, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IMVT